Literature DB >> 31251124

Low level of exosomal long non-coding RNA HOTTIP is a prognostic biomarker in colorectal cancer.

Florian Oehme1, Stefan Krahl1, Balazs Gyorffy2,3, Benjamin Muessle1, Venkatesh Rao1, Helena Greif1, Nicole Ziegler1,4, Kuailu Lin1, May-Linn Thepkaysone1, Heike Polster1, Torsten Tonn5, Martin Schneider6, Juergen Weitz1, Franziska Baenke1,4, Christoph Kahlert1.   

Abstract

Molecular risk stratification of colorectal cancer can improve patient outcome. A panel of lncRNAs (H19, HOTTIP, HULC and MALAT1) derived from serum exosomes of patients with non-metastatic CRC and healthy donors was analyzed. Exosomes from healthy donors carried significantly more H19, HULC and HOTTIP transcripts in comparison to CRC patients. Correlation analysis between lncRNAs and clinical data revealed a statistical significance between low levels of exosomal HOTTIP and poor overall survival. This was confirmed by multivariate analysis that HOTTIP is an independent prognostic marker for overall survival (HR: 4.5, CI: 1.69-11.98, p = 0.0027). Here, HOTTIP poses to be a valid biomarker for patients with a CRC to predict post-surgical survival time.

Entities:  

Keywords:  Exosomes; colorectal cancer; diagnosis; liquid biopsy; long non-coding RNA

Mesh:

Substances:

Year:  2019        PMID: 31251124      PMCID: PMC6779381          DOI: 10.1080/15476286.2019.1637697

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  32 in total

Review 1.  Extracellular vesicles in cancer - implications for future improvements in cancer care.

Authors:  Rong Xu; Alin Rai; Maoshan Chen; Wittaya Suwakulsiri; David W Greening; Richard J Simpson
Journal:  Nat Rev Clin Oncol       Date:  2018-10       Impact factor: 66.675

2.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Authors:  Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf O Bechstein; John N Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Murielle Mauer; Erik Tanis; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Journal:  Lancet Oncol       Date:  2013-10-11       Impact factor: 41.316

3.  Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention.

Authors:  Christiane Klec; Tony Gutschner; Katrin Panzitt; Martin Pichler
Journal:  Expert Opin Ther Targets       Date:  2019-01-24       Impact factor: 6.902

4.  Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.

Authors:  Ying-Kun Ren; Yan Xiao; Xiang-Bin Wan; Yu-Zhou Zhao; Jian Li; Yin Li; Guang-Sen Han; Xiao-Bing Chen; Qi-Yun Zou; Gang-Cheng Wang; Chao-Min Lu; Yong-Chao Xu; You-Cai Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression.

Authors:  Yifan Lian; Jie Ding; Zhihong Zhang; Yongguo Shi; Ya Zhu; Juan Li; Peng Peng; Jirong Wang; Yingrui Fan; Wei De; Keming Wang
Journal:  Tumour Biol       Date:  2015-12-17

Review 6.  Targeting metastasis.

Authors:  Patricia S Steeg
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

7.  MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation.

Authors:  Chuanqing Wu; Xiaojie Zhu; Kaixiong Tao; Weizhen Liu; Tuo Ruan; Wenze Wan; Chun Zhang; Weikang Zhang
Journal:  Mol Carcinog       Date:  2018-07-12       Impact factor: 4.784

8.  The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer.

Authors:  Wei-Cheng Liang; Wei-Ming Fu; Cheuk-Wa Wong; Yan Wang; Wei-Mao Wang; Guo-Xin Hu; Li Zhang; Li-Jia Xiao; David Chi-Cheong Wan; Jin-Fang Zhang; Mary Miu-Yee Waye
Journal:  Oncotarget       Date:  2015-09-08

9.  Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3.

Authors:  Dong Han; Xu Gao; Meng Wang; Yu Qiao; Ya Xu; Jing Yang; Nazhen Dong; Jun He; Qian Sun; Guixiang Lv; Changqing Xu; Ji Tao; Ning Ma
Journal:  Oncotarget       Date:  2016-04-19

10.  Long noncoding RNA HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma.

Authors:  Lihua Tang; Wei Zhang; Bing Su; Bo Yu
Journal:  Biomed Res Int       Date:  2013-06-05       Impact factor: 3.411

View more
  26 in total

Review 1.  The value of exosome-derived noncoding RNAs in colorectal cancer proliferation, metastasis, and clinical applications.

Authors:  Wenjie Zhang; Zhengting Jiang; Dong Tang
Journal:  Clin Transl Oncol       Date:  2022-08-03       Impact factor: 3.340

Review 2.  Extracellular vesicles and particles impact the systemic landscape of cancer.

Authors:  Serena Lucotti; Candia M Kenific; Haiying Zhang; David Lyden
Journal:  EMBO J       Date:  2022-09-02       Impact factor: 14.012

3.  Identification of a three-miRNA signature as a novel prognostic model for papillary renal cell carcinoma.

Authors:  Ge Li; Haifan Yang; Yong Cheng; Xin Zhao; Xu Li; Rui Jiang
Journal:  Cancer Cell Int       Date:  2020-07-16       Impact factor: 5.722

4.  lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling.

Authors:  Xiaoting Lin; Shiwen Zhuang; Xue Chen; Jun Du; Longhua Zhong; Jiancheng Ding; Lei Wang; Jia Yi; Guosheng Hu; Guohui Tang; Xi Luo; Wen Liu; Feng Ye
Journal:  Mol Ther       Date:  2021-08-08       Impact factor: 11.454

Review 5.  Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles.

Authors:  Irène Tatischeff
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 6.  LncRNAs as Chromatin Regulators in Cancer: From Molecular Function to Clinical Potential.

Authors:  Rodiola Begolli; Nikos Sideris; Antonis Giakountis
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

7.  Long noncoding RNA RHPN1-AS1 promotes colorectal cancer progression via targeting miR-7-5p/OGT axis.

Authors:  Wei Zheng; Hui Li; Hui Zhang; Chao Zhang; Zhonglin Zhu; Hong Liang; Yifeng Zhou
Journal:  Cancer Cell Int       Date:  2020-02-18       Impact factor: 5.722

Review 8.  Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer.

Authors:  Amro Baassiri; Farah Nassar; Deborah Mukherji; Ali Shamseddine; Rihab Nasr; Sally Temraz
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

Review 9.  Biological functions and clinical applications of exosomal long non-coding RNAs in cancer.

Authors:  Yali Wang; Mengdi Zhang; Fangfang Zhou
Journal:  J Cell Mol Med       Date:  2020-09-14       Impact factor: 5.310

Review 10.  Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer.

Authors:  L Yang; X Zhang; G Hu
Journal:  Clin Transl Oncol       Date:  2021-07-18       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.